Davy James, Associate Editor

Increased number of patients moving away from breast conservation surgery in early stages of disease.

First-line therapy with abatacept in combination with methotrexate achieved significantly higher rates of stringent measures of remission in patients with early rheumatoid arthritis.

Treatment found to reduce micro vasculature thrombosis formation.

Oral drug combination effective in treating newly diagnosed multiple myeloma.

Cases still increasing in Sierra Leone despite drop in new cases in other countries.

Progress in stopping the spread of the Ebola has been achieved in 2 West African countries, though new cases of the virus are increasing in a third.

Major emphasis placed on training efforts throughout the US.

Combination therapy eliminates tumors in more than 70% of mice.

With administrators increasing staff training efforts for the Ebola virus at medical facilities throughout the United States, hospital radiology departments are emphasizing protocols for performing imaging procedures on isolated patients.

Cyclophosphamide found to improve the success of virus therapy in patients with malignant gliomas.

Next generation drug shows anti-cancer activity in 10 of 11 tumor samples during lab tests.

Researchers find optimal combination and dosage for three common antirheumatic drugs.

Research may lead to more effective treatments in the future.

Drugs commonly used to treat osteoporosis may benefit patients with diseases like breast cancer.

With a mission to help pharmacists throughout the world prevent the potential spread of the Ebola virus, the International Pharmaceutical Federation has launched a suite of resources to advise community pharmacists on the threat.

Bevacizumab with chemotherapy reduced risk of disease progression by 62% compared with chemotherapy alone.

Three-drug regimen will lead to new treatment protocols for transplant patients, study finds.

Group launches suite of Ebola resources for community pharmacists.

The FDA today approved a new indication for an oncology drug that significantly reduces ovarian cancer disease progression.

RAND Corporation projects biosimilars to cause an approximately 4% reduction in total US biologic spending from 2014 to 2024.

Clinical trials to launch at 3 sites in West Africa.

While the Ebola scare has started to fade away in the United States, the crisis continues to devastate West Africa, where the death toll has climbed above 5000 with more than 14000 confirmed and suspected cases.

Researchers continue to seek more effective treatments for virus.

Enhancing supportive care improves the chances of a patient surviving an Ebola infection.

Salveo currently manages approximately $400 million in annual drug spend.

American doctor released from New York hospital today.

A New York City physician who became infected with Ebola after treating patients in West Africa was released from the hospital after being declared virus free.

Cost of medication causes financial burden for nearly two-thirds of patients.

A novel SMS platform initially designed to help people manage diabetes helps to warn the public.

A potential Ebola outbreak in Senegal was snuffed out thanks in part to an innovative text-messaging program originally intended to help patients with diabetes manage their disease.